Skip to content
PubMed This is a summary of 23 peer-reviewed journal articles Updated
Neurology · Secondary Postural Orthostatic Tachycardia Syndrome

What Causes Secondary POTS? Triggers & Conditions Explained

At a Glance

Secondary POTS is triggered by an underlying medical condition that damages the autonomic nervous system. The most common causes include viral infections like COVID-19, autoimmune diseases such as Sjögren’s syndrome, and metabolic disorders like diabetes. Treating the root cause can improve symptoms.

When you are diagnosed with Postural Orthostatic Tachycardia Syndrome (POTS), your doctor will likely try to determine whether your condition is “primary” or “secondary.” While primary POTS happens on its own without a clear underlying medical cause, secondary POTS is triggered by another identifiable disease or condition that damages the autonomic nervous system [1]. In secondary POTS, your body’s ability to maintain proper blood flow and vascular tone is impaired by a specific underlying issue [1]. This often involves small fiber neuropathy, which is damage to the small nerve endings that control involuntary bodily functions like heart rate and blood pressure [2].

The most common causes of secondary POTS include viral infections, immune conditions, metabolic disorders, and certain protein abnormalities [3]. Identifying the cause is an important part of your care journey, as addressing the root issue can significantly improve your symptoms.

Viral Infections

Many people with POTS can trace the onset of their symptoms back to a severe viral illness. Viruses can trigger a prolonged immune response or lead to post-viral autonomic dysregulation [4].

  • COVID-19: A notable number of people who develop “long COVID” or post-acute sequelae of SARS-CoV-2 (PASC) meet the criteria for a POTS diagnosis [5][6].
  • Epstein-Barr Virus (EBV): The virus responsible for infectious mononucleosis (mono) has also been documented as a trigger for POTS [4].

Immune and Autoimmune Conditions

In autoimmune diseases, your immune system mistakenly attacks your own body. If it attacks the nerves that control your heart rate and blood vessels, secondary POTS can develop [7].

  • Sjögren’s Syndrome: This autoimmune condition (which classically causes severe dry eyes and mouth) is a well-documented cause of secondary POTS [8]. In some patients, the presence of specific autoantibodies (like anti-gAChR) indicates that the immune system is targeting the autonomic nervous system [9].
  • Mast Cell Activation Syndrome (MCAS): MCAS is an immunological disorder where immune cells release too many chemical mediators (like histamine). While not strictly an autoimmune disease, it frequently coexists with POTS and can drive severe autonomic symptoms [10][7].
  • Note on Joint Hypermobility: While typically considered a distinct comorbidity rather than a secondary cause, conditions like Ehlers-Danlos Syndrome (EDS) and joint hypermobility spectrum disorders are very frequently seen alongside POTS and MCAS [11][3].

Metabolic and Infiltrative Diseases

Conditions that cause widespread nerve damage or abnormal protein buildup in tissues can also disrupt the autonomic nervous system.

  • Diabetic Neuropathy: Prolonged high blood sugar from diabetes can damage the sympathetic nerves responsible for controlling blood vessels. While more commonly associated with orthostatic hypotension, diabetes is a known cause of secondary autonomic dysfunction and sometimes POTS [12].
  • Amyloidosis: This rare disease occurs when an abnormal protein called amyloid builds up in your organs and tissues. Certain hereditary forms (like ATTRv amyloidosis) can cause early cardiovascular autonomic dysfunction [13][14].

Paraneoplastic Syndromes

Rarely, secondary POTS can be triggered by a paraneoplastic syndrome [15]. This is an immune response triggered by a cancerous tumor (such as small cell lung cancer or bladder cancer) [16][17]. Instead of the tumor directly pressing on nerves, the immune system creates antibodies to fight the cancer, which mistakenly attack the autonomic nervous system [15]. Because of this, autonomic symptoms can sometimes be the very first sign of an undiagnosed cancer [17].

Please do not panic if you read this. Paraneoplastic syndromes are rare. If your doctor suspects this could be a factor, they will routinely screen for specific antibodies and conduct imaging to ensure your safety and provide peace of mind [15][18].

Managing Symptoms vs. Treating the Cause

If you have secondary POTS, standard symptom management (like increased salt, hydration, compression garments, or medications like ivabradine) remains a critical part of your care to improve your daily quality of life [19]. You do not have to wait to find a root cause before you start treating your POTS symptoms.

However, finding and addressing the underlying condition is a crucial goal for long-term improvement [20]. For treatable triggers—like an autoimmune disease or a paraneoplastic syndrome—therapies that calm the immune system or address a tumor can lead to significant improvements, and sometimes a complete regression of autonomic symptoms [15][21]. For post-viral triggers, where the virus is already gone, the focus shifts to supporting your body’s recovery and managing the immune aftermath.

What an Autonomic Evaluation Looks Like

To uncover secondary causes, work closely with a specialist for a comprehensive autonomic evaluation [20]. This process can take time, so be patient with yourself and your care team. An evaluation may include:

  • Detailed Medical History: Discussing when symptoms started and your family history [22].
  • Tilt Table Testing: To monitor how your heart rate and blood pressure respond to changes in posture [23].
  • Autonomic Testing (like QSART): To measure how well your small nerve fibers control sweating.
  • Blood Panels: To check for autoimmune markers, metabolic issues, or specific autoantibodies (like gAChR) [20][9].
  • Neuropathy Biopsies: A small skin biopsy to check for small fiber nerve damage [2].

Common questions in this guide

What is the difference between primary and secondary POTS?
Primary POTS happens on its own without a clear underlying medical cause. Secondary POTS is triggered by another identifiable disease or condition, such as a virus or autoimmune disorder, that damages the autonomic nervous system.
Can a viral infection like COVID-19 cause POTS?
Yes, severe viral illnesses can trigger secondary POTS by causing a prolonged immune response or autonomic nerve damage. Both COVID-19 and the Epstein-Barr virus are known triggers for post-viral autonomic dysfunction.
What autoimmune conditions are linked to secondary POTS?
Autoimmune diseases like Sjögren’s syndrome can cause secondary POTS when the immune system mistakenly attacks the nerves controlling heart rate and blood vessels. Conditions like Mast Cell Activation Syndrome are also frequently seen alongside POTS.
How do doctors test for the underlying cause of secondary POTS?
Specialists conduct a comprehensive autonomic evaluation to uncover underlying causes. This may include a detailed medical history, tilt table testing, sweat tests like QSART, blood panels for autoimmune markers, and small skin biopsies to check for nerve damage.
Can I treat my POTS symptoms before finding the root cause?
Yes, you can and should start symptom management immediately to improve your quality of life. Standard treatments like increasing salt and hydration, wearing compression garments, and taking certain medications can be used while you and your doctor investigate underlying causes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given my medical history and symptom onset, what specific blood panels or tests should we run to check for underlying autoimmune, metabolic, or immune triggers?
  2. 2.Do you recommend a comprehensive autonomic evaluation, such as a tilt table test or a sweat test (QSART), to better understand the extent of my autonomic dysfunction?
  3. 3.Should I be referred to a specialized neurologist or rheumatologist to help investigate potential secondary causes of my POTS?
  4. 4.While we investigate potential underlying causes, what symptom management strategies (like medication or physical therapy) can we start immediately to improve my quality of life?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (23)
  1. 1

    Pathophysiological mechanisms of Postural Orthostatic Tachycardia Syndrome analyzed by means of hemodynamics.

    Wei L, Cheng H, Chen S, et al.

    PloS one 2025; (20(7)):e0327236 doi:10.1371/journal.pone.0327236.

    PMID: 40601666
  2. 2

    Skin Biopsy and Quantitative Sudomotor Axon Reflex Testing in Patients With Postural Orthostatic Tachycardia Syndrome.

    Zhang R, Mayuga K, Shields R, et al.

    Cureus 2022; (14(11)):e31021 doi:10.7759/cureus.31021.

    PMID: 36349067
  3. 3

    Dysautonomia in the Ehlers-Danlos syndromes and hypermobility spectrum disorders-With a focus on the postural tachycardia syndrome.

    Mathias CJ, Owens A, Iodice V, Hakim A

    American journal of medical genetics. Part C, Seminars in medical genetics 2021; (187(4)):510-519 doi:10.1002/ajmg.c.31951.

    PMID: 34766441
  4. 4

    New-onset Postural Orthostatic Tachycardia Syndrome Following Coronavirus Disease 2019 Infection.

    Kanjwal K, Jamal S, Kichloo A, Grubb BP

    The Journal of innovations in cardiac rhythm management 2020; (11(11)):4302-4304 doi:10.19102/icrm.2020.111102.

    PMID: 33262898
  5. 5

    Autonomic dysfunction and postural orthostatic tachycardia syndrome in post-acute COVID-19 syndrome.

    Fedorowski A, Sutton R

    Nature reviews. Cardiology 2023; (20(5)):281-282 doi:10.1038/s41569-023-00842-w.

    PMID: 36732397
  6. 6

    Autonomic neuropathy as post-acute sequela of SARS-CoV-2 infection: a case report.

    Agnihotri SP, Luis CVS, Kazamel M

    Journal of neurovirology 2022; (28(1)):158-161 doi:10.1007/s13365-022-01056-5.

    PMID: 35181863
  7. 7

    Successful treatment of postural orthostatic tachycardia and mast cell activation syndromes using naltrexone, immunoglobulin and antibiotic treatment.

    Weinstock LB, Brook JB, Myers TL, Goodman B

    BMJ case reports 2018; (2018()) doi:10.1136/bcr-2017-221405.

    PMID: 29326369
  8. 8

    Autonomic Nervous System Dysfunction in Primary Sjögren's Syndrome.

    Davies K, Ng WF

    Frontiers in immunology 2021; (12()):702505 doi:10.3389/fimmu.2021.702505.

    PMID: 34381453
  9. 9

    Insights from the ganglionic acetylcholine receptor autoantibodies in patients with Sjögren's syndrome.

    Mukaino A, Nakane S, Higuchi O, et al.

    Modern rheumatology 2016; (26(5)):708-15 doi:10.3109/14397595.2016.1147404.

    PMID: 26873295
  10. 10

    COVID-19 Dysautonomia.

    Goodman BP, Khoury JA, Blair JE, Grill MF

    Frontiers in neurology 2021; (12()):624968 doi:10.3389/fneur.2021.624968.

    PMID: 33927679
  11. 11

    Mechanisms underlying reflux symptoms and dysphagia in patients with joint hypermobility syndrome, with and without postural tachycardia syndrome.

    Fikree A, Aziz Q, Sifrim D

    Neurogastroenterology and motility 2017; (29(6)) doi:10.1111/nmo.13029.

    PMID: 28191707
  12. 12

    Postural Orthostatic Tachycardia in a Patient with Type 2 Diabetes with Diabetic Neuropathy.

    Tomichi Y, Kawano H, Mukaino A, et al.

    International heart journal 2018; (59(6)):1488-1490 doi:10.1536/ihj.17-628.

    PMID: 30305583
  13. 13

    Cardiovascular autonomic failure in hereditary transthyretin amyloidosis and TTR carriers is an early and progressive disease marker.

    Chiaro G, Stancanelli C, Koay S, et al.

    Clinical autonomic research : official journal of the Clinical Autonomic Research Society 2024; (34(3)):341-352 doi:10.1007/s10286-024-01038-z.

    PMID: 38769233
  14. 14

    Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy.

    Adams D, Ando Y, Beirão JM, et al.

    Journal of neurology 2021; (268(6)):2109-2122 doi:10.1007/s00415-019-09688-0.

    PMID: 31907599
  15. 15

    Paraneoplastic syndromes in ophthalmology.

    Parrado-Carrillo A, Alcubierre R, Camós-Carreras A, Sanchez-Dalmau BF

    Archivos de la Sociedad Espanola de Oftalmologia 2022; (97(6)):350-357 doi:10.1016/j.oftale.2022.03.006.

    PMID: 35292226
  16. 16

    Paraneoplastic syndromes in small cell lung cancer.

    Soomro Z, Youssef M, Yust-Katz S, et al.

    Journal of thoracic disease 2020; (12(10)):6253-6263 doi:10.21037/jtd.2020.03.88.

    PMID: 33209464
  17. 17

    Paraneoplastic autoimmune autonomic ganglionopathy as the first symptom of bladder cancer: a case report and review of literature.

    de Rojas Leal C, Lage-Sánchez JM, Pinel-Ríos J, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2022; (43(8)):4841-4845 doi:10.1007/s10072-022-06075-y.

    PMID: 35482157
  18. 18

    Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature: Part 5: Neurological auto-antibodies, discussion, flow chart, conclusions.

    Sculier C, Bentea G, Ruelle L, et al.

    Lung cancer (Amsterdam, Netherlands) 2017; (111()):164-175 doi:10.1016/j.lungcan.2017.07.026.

    PMID: 28838389
  19. 19

    Acceleration index predicts efficacy of orthostatic training on postural orthostatic tachycardia syndrome in children.

    Xu B, Gao Y, Zhang Q, et al.

    European journal of pediatrics 2024; (183(9)):4029-4039 doi:10.1007/s00431-024-05664-7.

    PMID: 38955847
  20. 20

    Pediatric postural orthostatic tachycardia syndrome: From mechanisms to individualized management.

    Xu W, Jin H, Liao Y, Du J

    Pediatric discovery.. 2024; (2(4)):e2509 doi:10.1002/pdi3.2509.

    PMID: 40626134
  21. 21

    Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) with postural orthostatic tachycardia syndrome after silicone breast implantation: Case report.

    de Carvalho JF, de Oliveira CBA, Boas RV, et al.

    European journal of rheumatology 2023; (10(1)):23-25 doi:10.5152/eurjrheum.2022.21108.

    PMID: 35156619
  22. 22

    Water Ingestion in Postural Orthostatic Tachycardia Syndrome: A Feasible Treatment Option?

    The Journal of innovations in cardiac rhythm management 2019; (10(2)):3545-3551 doi:10.19102/icrm.2019.100207.

    PMID: 32494413
  23. 23

    A cross-sectional study on upright heart rate and BP changing characteristics: basic data for establishing diagnosis of postural orthostatic tachycardia syndrome and orthostatic hypertension.

    Zhao J, Han Z, Zhang X, et al.

    BMJ open 2015; (5(6)):e007356 doi:10.1136/bmjopen-2014-007356.

    PMID: 26033944

This page provides educational information about the causes of secondary POTS. It is not medical advice. Always consult your neurologist, cardiologist, or primary care physician to investigate the specific underlying causes of your symptoms.

Get notified when new evidence is published on Postural Orthostatic Tachycardia Syndrome (POTS).

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.